This inventor holds 1 USPTO granted patent. Top assignee: Welfide Corporation. Active years: 2001.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2001
Title: Atsushi Sakai: Innovator in Pharmaceutical Composition
Introduction
Atsushi Sakai is a notable inventor based in Chikujo, Japan. He has made significant contributions to the field of pharmaceuticals, particularly in the development of drug compositions aimed at improving patient outcomes in organ transplantation and autoimmune diseases.
Latest Patents
Atsushi Sakai holds a patent for a drug composition that includes 2-amino-2-[2-(4-octylphenyl)ethyl]propane-1,3-diol or a pharmaceutically acceptable acid addition salt thereof. This composition can be formulated into a liquid preparation and is designed to suppress rejection in organ or bone marrow transplantation. It is also suitable for immunosuppressive sustention therapy and the treatment of autoimmune diseases.
Career Highlights
Sakai is associated with Welfide Corporation, where he continues to work on innovative pharmaceutical solutions. His expertise in drug formulation has positioned him as a key player in the industry.
Collaborations
Sakai collaborates with Rumiko Masuda, contributing to the advancement of pharmaceutical research and development.
Conclusion
Atsushi Sakai's work in drug composition exemplifies the impact of innovation in healthcare. His contributions are vital for improving therapies for patients undergoing organ transplantation and those suffering from autoimmune diseases.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile